Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

NCT00651729 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00651729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00651729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
December 31, 2004
Enrollment
279 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

muscle spasticity, stroke